Macro drivers include rising cervical spondylosis prevalence among desk-bound professionals, favorable reimbursement for post-operative immobilization in North America, and a shift toward lightweight, hypoallergenic materials such as thermoplastic elastomers and 3D-printed lattice structures. Competitive intensity has intensified as MedTech giants (e.g., Össur, BREG, DeRoyal) and Asian scale players race to launch disposable, antimicrobial, and customizable solutions. Regulatory momentum—particularly the EU MDR and FDA’s 510(k) reforms—is accelerating evidence-based design, while supply-chain dynamics favor near-shoring of critical foam and biocompatible resins. North America remains the largest region, capturing ~41% of 2025 revenue, whereas APAC (led by China and India) is the fastest-growing region, posting a 7.1% CAGR as public trauma-care programs expand and e-commerce channels proliferate.